Atara Biotherapeutics Investor Relations Material
Latest events
AGM 2024
Atara Biotherapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Atara Biotherapeutics Inc
Access all reports
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. The company develops its product candidates which is designed to harness the body's innate immune system to treat hematologic cancers including multiple myeloma. The company's research focuses on adoptive immunotherapy methodologies and next-generation products that utilize novel chimeric antigen receptors (CAR) technology to target specific antigens associated with a specific disease or condition.
Key slides for Atara Biotherapeutics Inc
Q1 2024
Atara Biotherapeutics Inc
Goldman Sachs 45th Annual Global Healthcare Conference
Atara Biotherapeutics Inc
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
ATRA
Country
🇺🇸 United States